
|Videos|April 11, 2020
Weekly Webinar Series Part 4: Managing Lung Cancer Patients Through the COVID-19 Pandemic
Advertisement
Led by Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; H. Jack West, MD; and Jarushka Naidoo, MBBch, MHS, these top leaders in the lung cancer space shared insights on the novel corona-virus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the healthcare system.
This webinar covered key information regarding:
- Insight from Jarushka Naidoo, MBBCh, and the general steps being taken by Johns Hopkins Medicine regarding COVID-19
- Immunotherapy adaptions in the era of COVID-19, with a special focus on pneumonitis
- Cased-based discussions surrounding imaging
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5




































